Michael Labellarte
Child & Adolescent Psychiatry · Towson, MDNPI 1659568137
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $78,285 of the $92,204 with a category attached, or 84.9%. Supernus Pharmaceuticals, Inc. accounts for 94.1% of it on its own, with 19 other manufacturers making up the rest. Among child & adolescent psychiatry clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 383 payments — averaging $240.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$87K
- Corium, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Lundbeck LLC$460
- Otsuka America Pharmaceutical, Inc.$440
- Johnson & Johnson$368
- plus $1K from 14 others
What the payments were for
- Consulting fees$2400%
- Speaking & faculty fees$78,28585%
- Travel & lodging$5,5466%
- Food & beverage$8,1289%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 160 | $86,732 |
| Corium, LLC | 27 | $1,981 |
| Takeda Pharmaceuticals U.S.A., Inc. | 65 | $1,006 |
| Lundbeck LLC | 28 | $460 |
| Otsuka America Pharmaceutical, Inc. | 26 | $440 |
| Johnson & Johnson | 13 | $368 |
| Neos Therapeutics, LP | 16 | $284 |
| Ironshore Pharmaceuticals Inc. | 10 | $190 |
| Shire North American Group Inc | 7 | $123 |
| Vertical Pharmaceuticals, LLC | 7 | $123 |
| AbbVie(2 entities) | 5 | $102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $87 |
| Tris Pharma Inc | 2 | $76 |
| OWP Pharmaceuticals, Inc. | 4 | $59 |
| Alkermes, Inc. | 2 | $43 |
| Noven Therapeutics, LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Adlon Therapeutics L.p. | 2 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| TMS Neurohealth Centers Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$92,204 in reported general payments places this provider in the 95th percentile of 98 child & adolescent psychiatry providers in Maryland.
See all child & adolescent psychiatry providers in Maryland →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 27 | $705 |
| Lamotrigine | 20 | $490 |
| Escitalopram Oxalate | 20 | $314 |
| Sertraline Hcl | 14 | $94 |
| Mirtazapine | 18 | $66 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Towson
- Anna GonzagaBaltimore$180K
- Sushma JaniColumbia$11K
- Dejan BudimirovicBaltimore$10K
- Sabah HadiFrederick$7K
- Adefolake OshodiRockville$4K
- Jonathan ShepherdWoodlawn$2K
- Suni JaniColumbia$2K
- Mertine JermanyEllicott City$2K
- Charles GordonRockville$1K
- Ibukun Olu IsaacsLeonardtown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.